Peptide FAQ

Peptides are shipped at room temperature, and are highly stable in the lyophilized form in sealed bags (Why in sealed bags?). Peptides should not be kept in solution for long periods of time.

Peptide storage guidelines: For long-term storage, peptides should be stored in lyophilized form at -20°C, or preferably at -80°C with desiccant in sealed containers to minimize peptide degradation. Under these conditions, peptides can be stored for up to several years. This type of storage prevents bacterial degradation, oxidation, and the formation of secondary structures.

Opening the package: It is better to equilibrate the peptides to room temperature in a desiccator prior to opening and weighing. Failure to warm the peptides beforehand can cause condensation to form (peptides tend to be hygroscopic) on the product when the bottle is opened. This will reduce the stability of the peptides.

Before reconstitution, centrifuge the vial of the lyophilized peptide at 12,000 x g for 20 seconds. This will help pellet the entire peptide sample for reconstitution.

Weighing peptides: Weigh out your required quantity of peptides rapidly and store all unused peptides at -20°C or below. Sequences that contain cysteine, methionine, tryptophan, asparagine, glutamine, and N-terminal glutamic acid will have a shorter shelf life than other peptides.

The solubility of a peptide in water cannot be predicted by studying its structure. However, the ε-amino group of Lys and the guanidine of Arg are usually helpful for estimating the solubility of peptides, particularly those with short sequences. In contrast, acidic peptides that contain Asp and Glu tend to be insoluble in water but can be dissolved easily in diluted ammonia or basic buffers.

Certain basic characteristics can be used to predict solubility:

1. Peptides containing <5 amino acids are commonly soluble in aqueous solutions. However, if the entire sequence consists of hydrophobic residues it will have only limited solubility or could be completely insoluble.
2. Hydrophilic peptides that contain >25% charged amino acids (E, D, K, R, and H) and <25% hydrophobic residues are usually soluble in aqueous solutions.
3. Hydrophobic peptides whose sequence contains ≥50% hydrophobic residues might be completely or only partially soluble in aqueous solutions. These peptides should instead be dissolved in organic solvents such as DMSO if they do not contain C, W, or M residues. If they do contain these amino acids, they should be dissolved in DMF, acetonitrile, isopropyl alcohol, ethanol, acetic acid, 4–8 M guanidine hydrochloride (GdnHCl), or urea prior to being diluted carefully in an aqueous solution.
4. Hydrophobic peptides that include >75% hydrophobic amino acids are generally not soluble in aqueous solutions. Instead, very strong solvents such as TFA or formic acid must be used for the initial solubilization. However, the peptide might precipitate when added to an aqueous buffered solution. As such, high concentrations of organic solvents or denaturants might be needed to dissolve these peptides.
5. Peptides that include a very high proportion (>75%) of D, E, H, K, N, Q, R, S, T, or Y can form intermolecular hydrogen bonds (cross-links), which can result in gel formation in concentrated aqueous solutions. Therefore, peptides should be dissolved in an organic solvent that is compatible with the final experiment. After dissolving the peptides in the organic solvent, the solution should be added slowly (dropwise) to a stirring aqueous buffered solution. The limit of solubility is reached when the resulting peptide solution begins to show turbidity.

Crude peptides are not recommended for biological assays. Crude peptides may contain large amounts of non-peptide impurities such as residual solvents, scavengers from cleavage, TFA, and other truncated peptides. TFA cannot be totally removed. Peptides are usually delivered as TFA salt. If residual TFA is a problem for your experiment, we recommend other salt forms such as acetate and hydrochloride. These salt forms are usually 20-30% more expensive than regular TFA salt. This is due to the peptide loss that takes place during the salt conversion and the greater amounts of raw materials required.

LifeTein^® recommends the following levels of peptide purity for various projects:

>75% purity

• Peptide arrays
• Antigens for antibody production
• Competitive elution chromatography
• ELISA standards for measuring antisera titers

>80% purity

• Western blotting studies (non-quantitative)
• Enzyme-substrate studies (non-quantitative)
• Peptide-blocking studies (non-quantitative)
• Affinity purification
• Phosphorylation assays
• Protein electrophoresis applications and immunocytochemistry

>95% purity

• ELISA standards and RIA protocols (quantitative)
• Receptor-ligand interaction studies (quantitative)
• In vitro bioassays and in vivo studies
• Enzyme studies and blocking assays (quantitative)
• NMR studies
• Mass spectrometry
• Other quantitative assays

>98% purity

• SAR Studies
• Clinical trials
• APIs (Active Pharmaceutical Ingredients)
• Commercial products
• X-ray crystallography studies
• Other sensitive experiments: enzyme-substrate studies, receptor-ligand interaction studies, blocking and competition assays

Peptide purity is the amount of the target peptide as determined by HPLC at 214 nm, where the peptide bond absorbs. Water and residual salts are not detected by a UV spectrophotometer. Other impurities that can be found in the content include deletion sequences (shorter peptides lacking one or more amino acids of the target sequence), truncated sequences (generated by capping steps to avoid the formation of deletion peptides), and incompletely deprotected sequences (generated during the synthesis or the final cleavage process).

Peptide purity does not include any water or salts in the sample. TFA results from HPLC purification. The free N-terminus and other side chains such as Arg, Lys, and His form trifluoroacetate, and this allow small amounts of TFA to contaminate the peptides. Peptides are usually delivered as trifluoroacetate containing residual water. Even in lyophilized peptides, varying amounts of noncovalently bound water still exist.

What are other substances (impurities) in the peptides?

The impurities in non-purified peptides are both peptides and non-peptides, and the impurities in purified peptides are mostly peptides with modified sequences, except for TFA salt.

1. Shorter peptides lacking one or more amino acids of the target sequence
2. Generated by capping steps to avoid the formation of deletion peptides
3. Generated during the synthesis or the final cleavage process
4. Reattachment of protecting groups at other locations on the peptide

The net peptide content is different from the peptide purity. The net peptide content is the percentage of peptides relative to nonpeptidic materials, mostly counterions and moisture. The net peptide content can be determined by amino acid analysis. Please place a request for a quote if you require this service. Usually, hydrophilic peptides absorb tiny amounts of moisture even under strict lyophilization conditions. Net peptide content may vary from batch to batch depending on the purification and lyophilization processes.

Peptides are usually delivered as TFA salts. If residual TFA would be problematic for your experiment, we recommend other salt forms such as acetate and hydrochloride. These salt forms are usually 20-30% more expensive than the regular TFA salt because of the peptide loss that takes place during the salt conversion and the greater amounts of raw materials required.

It is important that purified peptides be free of Trifluoroacetate (TFA) salts because TFA could alter the results of downstream biological assays.

The synthetic peptides are manufactured by solid-phase procedures. TFA is usually used for cleavage and purification steps. TFA binds to the free amino termini and side chains of positively charged amino acids. The TFA counterions could change the secondary structure, mass, solubility of peptides, or results of in vivo studies. 

All peptides from LifeTein are lyophilized to easily remove excess and unbound TFA. However, HPLC and salt exchange is required to remove the TFA counterions that are binding to the positively charged peptide residues. 

The most adapted method is to replace TFA counterions with a stronger acid such as hydrochloric acid (HCl). 

How to remove TFA from synthetic peptides using HCl?

1. Dissolve the peptide in distilled water at 1 mg (weight) per 1 mL of solvent. Phosphate buffer (50mM phosphate and 100mM NaCl) can be used instead of water.
2. Add 100 mM HCl to the peptide solution for a final HCl concentration between 2 mM and 10 mM. HCl concentration below 2 mM or higher than 10 mM may result in incomplete TFA exchange or modified peptides.
3. Allow the solution to stand at room temperature for at least a minute.
4. Freeze the solution at -20, -80, or preferably in liquid nitrogen.
5. Lyophilize overnight to remove all liquid.
6. Re-dissolve the lyophilized powder in an HCl solution.
7. Freeze the solution again and then lyophilize overnight.
8. Repeat steps 6 to 7 at least two times.
9. After the final lyophilization step re-dissolve the peptide in water or your desired buffer at around 2 mg (weight) per 1 mL of solvent.

Unlike natural protein synthesis, peptides are synthesized from the C to N-terminus. At LifeTein^®, peptide synthesis is performed using PeptideSyn technology based on Fmoc or t-Boc chemistry to protect the alpha-amino group. The deprotection agent (piperidine for Fmoc, TFA for Boc) frees the alpha-amino group in preparation for coupling the next amino acid in the sequence. This reveals a new N-terminal amine to which the next amino acid may be activated by one of the several reagents, forming a peptide bond. When the synthesis is complete, peptides are cleaved from the resin and deprotected. Peptides are then precipitated, washed, and lyophilized.

All materials supplied to LifeTein are considered the confidential property of the customer. LifeTein provides free HPLC and MS results with your package. Peptides are purified by reverse-phase chromatography. The chromatogram indicates the number and relative amount of by-products. The molecular mass of the peptide is determined by mass spectrometry to confirm that the correct product is being delivered. MS results also show the masses of the main impurities. Additional analysis revealing net peptide content can be performed upon request. Net peptide content is indicated by either amino acid analysis or elemental analysis. These methods allow the verification of the amino acid composition of the peptides. They serve as additional means of confirmation of peptide identity. All synthetic peptides meeting the customer's purity criteria are sent. All residual materials, such as peptides not meeting the customer's purity criteria are discarded. These residual materials can be sent to the customer upon request.

Upon request, LifeTein^® can aliquot part or all of your order into smaller quantities for a minimum fee of $3 per tube. Aliquoted products are more expensive but may save you time, effort and money during the determination of peptide solubility. Your peptides will also be more stable because they will not be exposed to as many freeze-thaw cycles, as many openings and closings of the container, mishandling, or bacterial contamination. Peptide oxidation, degradation, and aggregation are less prevalent in aliquoted samples.

APIs (active pharmaceutical ingredients) are the substances in drugs that are pharmaceutically active, such as oxytocin acetate, enfuvirtide acetate, and so on. Catalog peptides are commercially available sequences. They are usually produced in bulk at high levels of purity. These peptides are usually customized to customers' specific requests. For example, specific sequences, modifications, purity levels, or lengths may be required by the customer. The turnaround time for most API peptides is 2-3 weeks.

The minimum quantity to be ordered should be at least 1 mg. At LifeTein^®, There there is no maximum upper limit at LifeTein for research and or GMP peptides.

LifeTein^® has synthesized a peptide of 120 amino acids in length. Peptides of 50 amino acids are synthesized routinely.

Organic reactions are carried out on substrates covalently attached to a polymeric resin. Solid-phase synthesis can be better than traditional synthesis because the overall reaction takes place much more quickly, the process can be automated with robots, and synthetic intermediates do not need to be isolated because reagents are washed away during each step.

Resin is the polymeric backbone to which substrates are anchored. Different resins have different properties. For example, polystyrene swells in non-polar solvents, while polyethylene glycol swells in polar and non-polar solvents. Linkers are intermediate structures that attack the resin to the substrate. Different linkers can be used to unmask different functional groups on the substrate.

Protecting groups are fragments that bind to functional groups and block their reactivity. Some are acid-labile protecting groups such as Boc and tert-Bu ester. Some are base labile protecting groups such as Fmoc and Fm ester. Some others are fluoride-labile protecting groups such as Tmsec and Tmse ester. To ensure specific coupling between the required carboxyl and amino groups, the protecting groups should be easy to attach and remove without changing the rest of the peptide.

Chemically synthesized peptides carry free amino and carboxy termini. The need for N-terminal acetylation or C-terminal amidation must be stated explicitly during ordering. It is impossible to perform these modifications after synthesis has been completed.

N-terminal acetylation and C-terminal amidation reduce the overall charge of a peptide and decrease solubility. However, the stability of the peptide usually increases because the terminal acetylation and amidation allow the peptide to mimic the native protein more closely. In this way, these modifications may increase the peptide's biological activity.

Usually, dyes such as biotin and FITC can be introduced either N-terminally or C-terminally. We recommend N-terminus modification for its higher success rate, shorter turnaround time, and ease of operation. Peptides are synthesized from the C-terminus to the N-terminus. N-terminus modification is the last step in the SPPS protocol. No more specific coupling steps are required. In contrast, the C-terminus modification requires additional steps and is usually more complex.

Most dyes are large aromatic molecules. The incorporation of such bulky molecules may help to avoid interactions between the label and the peptide. This will help maintain peptide conformation and biological activity. It is recommended that a flexible spacer such as Ahx (a 6-carbon linker) be included to render the fluorescent label more stable. Otherwise, FITC could easily link to a cysteine thiol moiety or the amino group of lysine at any position.

Peptide purity is the term used to describe the percentage of the peptide with the target sequence among the total quantity of material. Because peptide bond formation is not 100% efficient during peptide synthesis, not all polypeptide chains are made of the target sequence. For example, some chains might not be complete, or amino acids might not bind appropriately. These deleted or incorrect sequences form a certain percentage of peptides in most peptide mixtures. We analyze and purify crude peptides using reverse-phase HPLC, and then analyze the resulting material using MS to achieve the desired target sequence purity.

After your peptide has been purified and lyophilized, the white peptide powder will contain some non-peptide components such as water, salts, absorbed solvents, and counter ions. The peptide content describes the actual percentage weight of the peptide in your final product. This number varies but is commonly 50–90% depending on the purity, sequence, and methods used for synthesis and purification. When calculating the concentration of peptide solutions for biological assays or other experiments, it is essential that the peptide content is accounted for. The actual peptide concentration can be determined by subtracting the non-peptide weight from the total weight, which allows you to determine what volume of solvent to use. For example, if you were using 1 mg of the final product to make a 1-mg/ml peptide solution with a content of 80%, you would use 800-μl of solvent rather than 1000 μl.

It is important to note that peptide content and peptide purity are two distinct measurements. Purity is determined using HPLC and revealed the presence or absence of contaminating peptides with the incorrect sequences. In contrast, the net peptide content provides only information regarding the percent of total peptide vs. total non-peptide components: it does not consider the presence of multiple peptides. The net peptide content can be determined accurately by performing amino acid analysis or UV spectrophotometry.

It is difficult to determine the actual concentration of a peptide based on the weight of the lyophilized peptide. Lyophilized peptides might contain 10–70% water and salts by weight. Generally, hydrophobic peptides contain less bound water and salts than do hydrophilic peptides.

If the peptide has a chromophore in its sequence (W or Y), the peptide concentration can be determined conveniently using the extinction coefficient of these residues as follows:

mg peptide/ml = (0.5AU x 50 x 3418 mg/mmole) / [(1 x 5560) + (2 x 1200)] AU/mmole/ml = 10.7

1. Molar extinction coefficients of chromophoric residues at 280 nm at neutral pH using a 1-cm cell:
   • Tryptophan 5560 AU/mmole/ml
   • Tyrosine 1200 AU/mmole/ml
2. The molar extinction coefficient of chromophoric residues is measured at 280 nm at neutral pH using a 1-cm cell. That of W is 5560 AU/mmole/ml, whereas that of Y is 1200 AU/mmole/ml
3. The extinction coefficient of the chromophores in a peptide sequence is generally additive; therefore, the overall molar extinction coefficient of the peptide depends on the type and number of the chromophoric residues in the sequence.
4. When performing the calculations, the mg peptide per ml = (A280 x DF x MW) / e, where A280 = the actual absorbance of the solution at 280 nm in a 1-cm cell, DF = dilution factor, MW = molecular weight of the peptide, and e = molar extinction coefficient of each chromophore at 280 nm.
5. Hypothetical example: A 50× diluted solution of the peptide with the sequence GRKKR RQRRR PPQQW DCDLY RPYEK T (MW = 3418) would measure 0.5 AU at 280 nm in a 1-cm cell. The concentration of the original peptide in the stock peptide solution would be calculated as follows:
6. Cautions:

• Any absorbance calculation assumes that a peptide is unfolded and that the chromophores are exposed. This is generally an acceptable assumption for short, soluble peptides. If there are doubts about the solubility or folding of a given peptide, it is advisable to perform the measurement under denaturing conditions (e.g., in the presence of 6 M GdnHCl or 8 M urea). It is important to remember that these peptide solutions will not be functional until the denaturants have been removed.
• If the sequence does not have W or Y amino acids, the peptide concentration can only be determined using amino acid analysis.

If your sample contains proteins of interest that are <20 kDa, please download a protocol that explains how to detect synthetic peptides using SDS-PAGE, including effective methods for Coomassie blue staining, silver staining, and electroblotting.

Tricine-based SDS-PAGE is used most commonly to separate proteins sized 1–100 kDa, and is the electrophoretic system of choice for resolving proteins <30 kDa. Although visualizing small peptides using SDS-PAGE is challenging, Tris-tricine gels afford better resolution. However, if you simply want to detect the peptide, MS remains the most accurate method for confirming the identity of a peptide.

Small peptides bind to Coomassie brilliant blue less readily than do larger proteins. Therefore, smaller peptides are difficult to detect using Coomassie or silver staining. The additional sample could be loaded to allow peptides to be visualized on gels; changing the percentage of the gel will only help if you think that your peptide migrated out gel. In this instance, the percentage of crosslinker in a regular 17% gel could be increased, and the pH of the resolving gel could be increased to 9.5 (compared with the normal 8.8). Finally, the addition of 4–8 M urea helps sharpen bands.

The use of Western blotting rather than gel staining is a far more sensitive detection method. However, the peptide might simply pass through the membrane during transfer. If you think this occurs, the experiment can be repeated using two pieces of membrane and a shorter transfer time (<1 hour at 200 mA). A membrane with a 0.2-μm pore size should be sufficient: although smaller pore sizes are available, they should not be necessary. An additional option would be to try semi-dry transfer for 15–20 minutes using the current density (mA/cm2) recommended for the apparatus. A short transfer time of 15 min works for most small peptides. If it is possible to plan ahead, a control small peptide labeled with biotin could be synthesized to monitor the transfer process and assess the ability of the peptide to bind to the membrane using streptavidin-conjugated HRP.

Dimethyl sulfoxide (DMSO) is an organosulfur compound with the formula (CH3)2SO. DMSO is used frequently in cell banking applications as a cryoprotectant because it prevents intracellular and extracellular crystals from forming in cells during the freezing process. For most cryopreservation applications, DMSO is used at a concentration of 10% and is usually combined with saline or serum albumin.

Hydrophobic peptides can be dissolved easily in DMSO. However, peptides in DMSO might be cytotoxic to cells, even though DMSO increases cell permeability. High concentrations of DMSO should never be used for cell culture. 5% is very high and will dissolve the cell membranes. Most cell lines can tolerate 0.5% DMSO, and some cells can tolerate up to 1% without severe cytotoxicity. However, primary cell cultures are far more sensitive. Therefore, if you are using primary cells a dose-response curve (viability) should be performed using DMSO concentrations <0.1%.

Try to dissolve very hydrophobic peptides in a small amount of DMSO (30–50 μl, 100%), and then slowly add the solution dropwise to a stirring aqueous buffered solution such as PBS (or your desired buffer) to the required concentration. If the resulting peptide solution begins to show turbidity, you have reached the limit of solubility. Sonication will help dissolve the peptides.

Rule of thumb:

• 0.1% DMSO is considered to be safe for almost all cells.
• A final concentration of 0.5% DMSO is used widely for cell culture without cytotoxicity.
• 1% DMSO does not cause any toxicity in some cells, but 0.5% DMSO is recommended.
• 5% DMSO was used successfully in some cells.
• To maintain a final concentration of 0.5%, you can make 200x stock in 100% DMSO.

Basic buffers should be avoided for peptides containing disulfide bridges. Peptides containing free thiol group may oxidize to form dimers or oligomers during storage, even as the lyophilized dry powder at a low temperature. Peptides provided as acetate salt are more sensitive to Cysteine oxidation than the corresponding TFA salt or HCL salt. The disulfide bond formation is rapid at neutral or slightly basic pH. Disulfide bridge formation is reversible. The disulfide bonds can be reduced at basic conditions using DTT. The pH 7-9.5 is the optimum pH-range for reductions with DTT. The DTT solutions should be freshly prepared because DTT is readily oxidized.

Peptides containing a single free cysteine will be oxidized at pH>7 to form dimers. This oxidation can be reverted. Peptides containing two or more thiol moieties may yield a mixture of products upon oxidation. A pH 7.5-8 is the best condition for the disulfide bond formation. Hence, peptides containing free cysteines are best dissolved in degassed solvents, e.g. buffers pH<7, diluted acetic acid, 0.1% trifluoroacetic acid in aqueous acetonitrile. DMSO should be avoided, especially with peptide trifluoroacetate.

The amyloid peptide Aβ (1-42), or other amyloid mutants may form insoluble aggregates during storage. Aβ (1-42) is soluble in hexafluoroisopropanol (HFIP), DMSO, 0.1% aqueous ammonia, 50 mM TRIS ∙ HCl, or 1mM NaOH. Reconstitution in HFIP or DMSO takes time whereas ammonia rapidly dissolves the peptide. The volatile solvent HFIP is usually evaporated leaving a residue of monomeric, soluble Aβ (1-42), which can be reconstituted with the chosen buffer at pH 7.4 to induce fibrillation. Aβ (1-42) solutions in DMSO or aqueous bases can be diluted directly with a working buffer.

Most peptides contain the basic functionalities: the guanidino group of Arg, the ε-amino group of Lys, the free N-terminus, and the imidazole moiety of His. These basic functionalities can form salts with acids. All our peptides are provided as trifluoroacetate salts unless specified otherwise. During cleavage from the carrier resin and purification, the peptide will react to the trifluoroacetic acid (a strong acid). Additional ion-exchange steps are needed to make the acetate salt or HCL salt form peptides. Some acidic peptides, containing Asp, Glu, phosphor group or sulfotyrosine, can form salts with bases and may be provided as ammonium salts.

Peptide folding is the process by which a peptide structure assumes its functional shape or conformation. By coiling and folding into a specific three-dimensional shape, the peptides are able to perform their biological function. The amino acids with hydrophobic side chains tend to end up clustered at the core of the structure so that they are out of contact with water. Covalent disulfide bridges can affect the shape of a protein. Protein folding is a spontaneous process because the Gibbs free energy is negative.